Cetrorelix is a synthetic decapeptide analogue of gonadotropin-releasing hormone (GnRH) studied in laboratory research as a GnRH receptor antagonist tool compound in vitro. This article summarizes its structure and how researchers characterize it in controlled laboratory settings only.

Structure: Cetrorelix carries multiple D-amino acid substitutions and a modified C-terminus relative to native GnRH, changes studied for their effect on antagonist binding at the GnRH receptor and stability in assay systems. Researchers confirm identity and purity by HPLC and mass spectrometry and review the lot-matched Certificate of Analysis before use in experiments.

Laboratory applications: In cell culture and receptor-binding assays, cetrorelix is used to probe GnRH receptor signaling by competitive antagonism, including inhibition of agonist-driven second-messenger and reporter-gene readouts in controlled systems. Study designs typically include vehicle controls, a reference agonist challenge, and analytical verification of the test article. No conclusions about human use can be drawn from in vitro work.

Analytical notes: Store lyophilized material as directed on the product label, protect from moisture, and document lot numbers in laboratory records.

Disclaimer: This product and this article are for laboratory research purposes only. Not for human consumption. Not for medical, therapeutic, diagnostic, or veterinary use. No dosing, reconstitution-for-use, or efficacy information is provided or implied.

Citations: GnRH receptor pharmacology reviews; standard HPLC/MS peptide characterization methods.